Senior Upstream Process Development Scientist with 5+ years of experience specializing in CHO media formulation, high density perfusion and cross scale bioreactor translation. Led development and commercialization of DG44 and perfusion media platforms delivering 37% increases in titer and up to 2-fold improvements in specific productivity. Experienced in perfusion intensification, steady state operations up to 150 M cell/ml, and engineering driven optimization using P/V, kLa and gas transfer strategies. Proven ability to translate small-scale models, (DWP, ambr15) to large stirred tank systems while improving productivity, robustness and scalability.
Poster Presentation-PEGS Boston
BalanCD CHO DG44 Media Development:
demonstrated improved titer versus supplier media across multiple DG44 cell lines and bioreactor scales
Jefferson Institute for Bioprocessing:
Completion of Techniques and Methods in Bioprocessing Operations